Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LMP2-loaded DC vaccine with or without DUK-CPG-001 in EBV+ lymphoma
NCT02115126Phase 2Withdrawn
- Start
- Dec 2016
- Primary completion
- Jan 2020
- Countries
- 1
01
Overview
A Phase 2 trial of DUK-CPG-001 in Hodgkin lymphoma (HL), non-Hodgkin lymphoma (NHL). Planned start Dec 2016; status: withdrawn.
02
Drugs
DUK-CPG-001
03
Conditions
Hodgkin lymphoma (HL)non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT02115126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02115126.